Esperion Therapeutics, Inc.
ESPR2026/7/13 下市- 產業
- Pharmaceutical Preparations
- SEC CIK
- 0001434868
Esperion Therapeutics, Inc. 已在 2026/7/13 下市；內部人最後一份 Form 4 在 2026/7/13 申報；2026 年第 2 季末有 192 家機構在 13F 申報持有，市值合計 $6.47 億；大師中只有索羅斯基金管理持有。
持有 ESPR 5% 以上的大股東
最新一份 Schedule 13D 或 13G 申報持有 Esperion Therapeutics, Inc. 5% 以上的持有人，依持股比例由大到小；變化是跟這位持有人的上一份申報比。
| 持有人 | 最新表單 | 持股 | 變化 | 首次申報 | 最新申報 | 原文 |
|---|---|---|---|---|---|---|
| Glazer Capital, LLC | 13G | 8.15%股數 2,098 萬 | 新申報 | 2026/6/81 份 | 2026/6/8 | SEC |
| Vanguard Capital Management LLC | 13G | 5.08%股數 1,311 萬 | 新申報 | 2026/7/311 份 | 2026/7/31 | SEC |
持股是每位持有人最新一份申報的數字。最後一份是舊格式（2024 年 12 月 18 日以前）的持有人沒有持股比例紀錄，不列在這裡；公司被收購或下市之後，持有人通常就不再申報。
13D 與 13G 申報
Esperion Therapeutics, Inc. 的 69 份 Schedule 13D、13G 申報，由新到舊，包括沒有持股比例的舊格式申報。
| 申報時間（美東） | 申報人 | 表單 | 持股 | 變化 | 事件日 | 原文 |
|---|---|---|---|---|---|---|
| 2026/11/1019:29 ET | Goldman Sachs Group Inc等 2 位 | 13G/A | 0.00%股數 0 | −6.70 個百分點原本 6.70%低於 5% | 2026/9/30 | SEC |
| 2026/8/1314:07 ET | Goldman Sachs Group Inc等 2 位 | 13G | 6.70%股數 1,722 萬 | 新申報 | 2026/6/30 | SEC |
| 2026/7/3110:20 ET | Vanguard Capital Management LLC | 13G | 5.08%股數 1,311 萬 | 新申報 | 2026/6/30 | SEC |
| 2026/7/1417:08 ET | Wasatch Advisors Inc | 13G/A | 0.70%股數 193.0 萬 | −5.40 個百分點原本 6.10%低於 5% | 2026/6/30 | SEC |
| 2026/6/817:10 ET | Glazer Capital, LLC等 2 位 | 13G | 8.15%股數 2,098 萬 | 新申報 | 2026/6/1 | SEC |
| 2026/4/2215:44 ET | Wasatch Advisors Inc | 13G | 6.10%股數 1,577 萬 | +2.60 個百分點原本 3.50% | 2026/3/31 | SEC |
| 2026/3/2618:22 ET | Vanguard Group Inc | 13G/A | 0.00%股數 0 | –低於 5% | 2026/3/13 | SEC |
| 2025/11/1411:43 ET | Two Seas Capital LP等 3 位 | 13G/A | 4.70%股數 975.0 萬 | −0.30 個百分點原本 5.00%低於 5% | 2025/9/30 | SEC |
| 2025/11/1215:32 ET | Wasatch Advisors Inc | 13G/A | 3.50%股數 706.2 萬 | −2.00 個百分點原本 5.50%低於 5% | 2025/9/30 | SEC |
| 2025/8/1317:47 ET | Two Seas Capital LP等 3 位 | 13G | 5.00%股數 995.5 萬 | – | 2025/6/30 | SEC |
| 2025/4/714:15 ET | Wasatch Advisors Inc | 13G/A | 5.50%股數 1,093 萬 | – | 2025/3/31 | SEC |
| 2025/3/1011:12 ET | BB Biotech AG等 2 位 | 13G/A | 4.90%股數 969.4 萬 | −0.10 個百分點原本 5.00%低於 5% | 2025/3/4 | SEC |
| 2025/2/1414:37 ET | BB Biotech AG等 2 位 | 13G/A | 5.00%股數 994.4 萬 | – | 2024/12/31 | SEC |
| 2024/11/14 | Two Seas Capital LP | 13G/A舊制 | – | – | – | SEC |
| 2024/11/12 | Vanguard Group Inc | 13G/A舊制 | – | – | – | SEC |
| 2024/11/8 | BlackRock, Inc. | 13G舊制 | – | – | – | SEC |
| 2024/11/4 | Vanguard Group Inc | 13G/A舊制 | – | – | – | SEC |
| 2024/11/4 | Vanguard Group Inc | 13G/A舊制 | – | – | – | SEC |
| 2024/10/22 | BlackRock, Inc. | 13G舊制 | – | 新申報 | – | SEC |
| 2024/10/17 | Millennium Management LLC | 13G/A舊制 | – | – | – | SEC |
| 2024/6/12 | Millennium Management LLC | 13G舊制 | – | – | – | SEC |
| 2024/2/14 | Two Seas Capital LP | 13G/A舊制 | – | – | – | SEC |
| 2024/2/14 | Deep Track Capital, LP | 13G/A舊制 | – | – | – | SEC |
| 2024/2/14 | CVI Investments, Inc. | 13G/A舊制 | – | – | – | SEC |
| 2024/2/14 | Point72 Asset Management, L.P. | 13G/A舊制 | – | – | – | SEC |
| 2024/2/13 | Vanguard Group Inc | 13G/A舊制 | – | – | – | SEC |
| 2024/2/9 | Wasatch Advisors Inc | 13G/A舊制 | – | – | – | SEC |
| 2024/1/24 | BB Biotech AG | 13G/A舊制 | – | – | – | SEC |
| 2024/1/24 | BB Biotech AG | 13G/A舊制 | – | – | – | SEC |
| 2024/1/17 | Millennium Management LLC | 13G/A舊制 | – | – | – | SEC |
| 2024/1/3 | Meditor Group Ltd | 13G/A舊制 | – | – | – | SEC |
| 2023/10/5 | Two Seas Capital LP | 13G舊制 | – | 新申報 | – | SEC |
| 2023/8/29 | Millennium Management LLC | 13G舊制 | – | – | – | SEC |
| 2023/8/28 | Millennium Management LLC | 13G舊制 | – | – | – | SEC |
| 2023/6/813:25 ET | BlackRock Inc. | 13G/A舊制 | – | – | – | SEC |
| 2023/4/5 | Point72 Asset Management, L.P. | 13G舊制 | – | – | – | SEC |
| 2023/2/14 | BB Biotech AG | 13G/A舊制 | – | – | – | SEC |
| 2023/2/14 | CVI Investments, Inc. | 13G/A舊制 | – | – | – | SEC |
| 2023/2/14 | Point72 Asset Management, L.P. | 13G/A舊制 | – | – | – | SEC |
| 2023/2/10 | Wasatch Advisors Inc | 13G/A舊制 | – | – | – | SEC |
| 2023/2/9 | Vanguard Group Inc | 13G/A舊制 | – | – | – | SEC |
| 2023/2/713:06 ET | BlackRock Inc. | 13G舊制 | – | – | – | SEC |
| 2023/1/20 | Millennium Management LLC | 13G舊制 | – | 新申報 | – | SEC |
| 2023/1/4 | Meditor Group Ltd | 13G/A舊制 | – | – | – | SEC |
| 2022/8/23 | Point72 Asset Management, L.P. | 13G舊制 | – | 新申報 | – | SEC |
| 2022/5/17 | Flynn James E | 13G/A舊制 | – | – | – | SEC |
| 2022/2/14 | CVI Investments, Inc. | 13G/A舊制 | – | – | – | SEC |
| 2022/2/11 | Flynn James E | 13G/A舊制 | – | – | – | SEC |
| 2022/2/11 | BB Biotech AG | 13G/A舊制 | – | – | – | SEC |
| 2022/2/11 | Wasatch Advisors Inc | 13G/A舊制 | – | – | – | SEC |
Form 144：內部人預計賣出
高階主管、董事與其他關係人預計賣出 Esperion Therapeutics, Inc. 股票的 52 份通知，由新到舊。
| 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|
| 2026/6/1715:34 ET | Koenig Sheldon L.高階主管 · 董事 | 5.36 萬 | $16.9 萬 | 2026/6/17 | Fidelity Brokerage Services LLC | SEC |
| 2026/6/1715:23 ET | Halladay Benjamin高階主管 | 1.08 萬 | $3.40 萬 | 2026/6/17 | Fidelity Brokerage Services LLC | SEC |
| 2026/6/1715:11 ET | Looker Benjamin高階主管 | 1.18 萬 | $3.73 萬 | 2026/6/17 | Fidelity Brokerage Services LLC | SEC |
| 2026/3/1715:19 ET | Halladay Benjamin高階主管 | 6,424 | $1.74 萬 | 2026/3/17 | Fidelity Brokerage Services LLC | SEC |
| 2026/3/1715:17 ET | Looker Benjamin高階主管 | 5,708 | $1.54 萬 | 2026/3/17 | Fidelity Brokerage Services LLC | SEC |
| 2026/3/1715:12 ET | Koenig Sheldon L.高階主管 · 董事 | 2.56 萬 | $6.96 萬 | 2026/3/17 | Fidelity Brokerage Services LLC | SEC |
| 2026/1/2015:14 ET | Looker Benjamin高階主管 | 1,689 | $4,867.02 | 2026/1/20 | Fidelity Brokerage Services LLC | SEC |
| 2025/12/1715:52 ET | Koenig Sheldon L.高階主管 · 董事 | 4.82 萬 | $17.7 萬 | 2025/12/17 | Fidelity Brokerage Services LLC | SEC |
| 2025/12/1715:26 ET | Looker Benjamin高階主管 | 6,517 | $2.39 萬 | 2025/12/17 | Fidelity Brokerage Services LLC | SEC |
| 2025/12/1715:18 ET | Halladay Benjamin高階主管 | 7,337 | $2.69 萬 | 2025/12/17 | Fidelity Brokerage Services LLC | SEC |
| 2025/10/1715:13 ET | Looker Benjamin高階主管 | 1,248 | $3,275.38 | 2025/10/17 | Fidelity Brokerage Services LLC | SEC |
| 2025/9/1715:37 ET | Koenig Sheldon L.高階主管 · 董事 | 2.84 萬 | $7.92 萬 | 2025/9/17 | Fidelity Brokerage Services LLC | SEC |
| 2025/9/1715:30 ET | Halladay Benjamin高階主管 | 7,046 | $1.98 萬 | 2025/9/17 | Fidelity Brokerage Services LLC | SEC |
| 2025/9/1715:25 ET | Looker Benjamin高階主管 | 6,267 | $1.76 萬 | 2025/9/17 | Fidelity Brokerage Services LLC | SEC |
| 2025/7/1717:09 ET | Looker Benjamin高階主管 | 1,304 | $1,469.35 | 2025/7/17 | Fidelity Brokerage Services LLC | SEC |
| 2025/7/1715:39 ET | Halladay Benjamin高階主管 | 11 | $12.27 | 2025/7/17 | Fidelity Brokerage Services LLC | SEC |
| 2025/6/1716:11 ET | Koenig Sheldon L.高階主管 · 董事 | 3.05 萬 | $3.38 萬 | 2025/6/17 | Fidelity Brokerage Services LLC | SEC |
| 2025/6/1715:34 ET | Halladay Benjamin高階主管 | 7,229 | $8,329.25 | 2025/6/17 | Fidelity Brokerage Services LLC | SEC |
| 2025/6/1715:16 ET | Looker Benjamin高階主管 | 6,422 | $7,397.5 | 2025/6/17 | Fidelity Brokerage Services LLC | SEC |
| 2025/4/1715:14 ET | Halladay Benjamin高階主管 | 8 | $7.71 | 2025/4/17 | Fidelity Brokerage Services LLC | SEC |
| 2025/4/1715:08 ET | Warren Eric高階主管 | 108 | $105.57 | 2025/4/17 | Fidelity Brokerage Services LLC | SEC |
| 2025/3/1815:23 ET | Warren Eric高階主管 | 2,433 | $3,618.12 | 2025/3/18 | Fidelity Brokerage Services LLC | SEC |
| 2025/3/1815:20 ET | Halladay Benjamin高階主管 | 3,535 | $5,243.1 | 2025/3/18 | Fidelity Brokerage Services LLC | SEC |
| 2025/3/1815:11 ET | Koenig Sheldon L.高階主管 · 董事 | 1.30 萬 | $1.96 萬 | 2025/3/18 | Fidelity Brokerage Services LLC | SEC |
| 2025/2/1915:34 ET | Warren Eric高階主管 | 239 | $446.43 | 2025/2/19 | Fidelity Brokerage Services LLC | SEC |
只列最新的 25 份。看 ESPR 近 12 個月的全部通知